Authors
Amber M Brown, Leah Stallkamp, April L Rahrig, Courtney M Rowan
Published in
Pediatric blood & cancer. Pages e70731. Oct 05, 2026. Epub Oct 05, 2026.
Abstract
Veno-occlusive disease (VOD) is a common complication post-hematopoietic stem cell transplant (HSCT) and is associated with increased mortality. Factors predictive of outcomes are lacking. Albumin-bilirubin (ALBI) score is used to quantify liver function and prognosticate but has not been investigated in VOD.
Single-center retrospective study investigating the ALBI score in children aged 0-26 years who underwent HSCT from 2019 to 2024 and developed VOD. Primary outcome was hospital mortality. ALBI score was calculated at time points chosen a priori spanning preconditioning to post-VOD diagnosis.
Forty-three patients developed VOD. Most were transplanted for cancer (n = 33, 77%). Seven (16%) died. Preconditioning median ALBI scores did not differ between survivors and non-survivors. Median ALBI scores significantly increased from preconditioning -3.00 (IQR: -3.10, -2.80) to VOD diagnosis -1.70 (IQR: -2.00, -1.50), p < 0.001. In the week after VOD diagnosis, ALBI scores improved in survivors but worsened in non-survivors. ALBI scores 7 days post-VOD diagnosis were higher in non-survivors (p = 0.008, AUC = 0.83). Using an established cutoff, severe ALBI on day 7 post-VOD diagnosis had greater mortality odds (OR = 8.3 [95% CI: 1.4, 48.5], p = 0.02). Those who died trended toward higher ALBI 3 days prior to VOD diagnosis than those who survived, -1.70 (IQR: -1.90, -1.30) versus -2.10 (IQR: -2.40, -1.80), p = 0.16.
In this cohort, ALBI score worsened with VOD diagnosis and at 7 days post-diagnosis was associated with mortality. The ALBI score is easily obtained and may aid in VOD prognostication.
PMID:
42831661
Bibliographic data and abstract were imported from PubMed on 05 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 13
- Comments 0